Key Financial’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Key Financial's TGTX Position: Q3 2026 in Review
Key Financial held its TG Therapeutics (TGTX) position steady in Q3 2026 at 2,000 shares worth $112K. The position accounts for 0.02% of the portfolio, ranked #395.
Key Financial first reported a position in TGTX in Q1 2020 and has held it in 25 quarters since. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Key Financial held 2,000 shares of TG Therapeutics worth $112K as of Q3 2026.
- Key Financial left its TG Therapeutics share count unchanged in Q3 2026.
- TG Therapeutics made up 0.02% of Key Financial's portfolio in Q3 2026, its #395 holding.
- Key Financial first reported a position in TG Therapeutics in Q1 2020 and has held it in 25 quarters since.
- 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.